Results 1 to 10 of about 272,686 (351)

Angiotensin II Type 1 Receptor Blockers [PDF]

open access: yesCirculation, 2001
In the 1970s, a series of observations demonstrated that angiotensin II has deleterious effects on the heart and kidney and that patients with high levels of plasma renin activity are at a higher risk of developing stroke or myocardial infarction than those with low plasma renin activity.1 2 Thereafter, the development of pharmacological probes that ...
M. Burnier
openaire   +3 more sources

Advances in the allostery of angiotensin II type 1 receptor [PDF]

open access: yesCell & Bioscience, 2023
Angiotensin II type 1 receptor (AT1R) is a promising therapeutic target for cardiovascular diseases. Compared with orthosteric ligands, allosteric modulators attract considerable attention for drug development due to their unique advantages of high ...
Xi Zhang   +4 more
doaj   +2 more sources

Angiotensin II modulates THP-1-like macrophage phenotype and inflammatory signatures via angiotensin II type 1 receptor [PDF]

open access: yesFrontiers in Cardiovascular Medicine, 2023
Angiotensin II (Ang II) is a major component of the renin–angiotensin or renin–angiotensin–aldosterone system, which is the main element found to be involved in cardiopathology.
Tlili Barhoumi   +7 more
doaj   +2 more sources

Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
BackgroundBoth the adrenergic and renin‐angiotensin systems contribute to orthostatic circulatory homeostasis, which is impaired in postural orthostatic tachycardia syndrome (POTS).
Xichun Yu   +9 more
doaj   +2 more sources

The angiotensin II type 1 receptor and receptor-associated proteins [PDF]

open access: yesCell Research, 2001
The mechanisms of regulation, activation and signal transduction of the angiotensin II (Ang II) type 1 (AT1) receptor have been studied extensively in the decade after its cloning. The AT1 receptor is a major component of the renin-angiotensin system (RAS). It mediates the classical biological actions of Ang II.
D F, Guo, Y L, Sun, P, Hamet, T, Inagami
openaire   +3 more sources

miR-155 suppresses angiotensin II type 1 receptor synthesis during placental morphogenesis [PDF]

open access: yesCell Death Discovery
Several microRNAs play vital roles in placental development. miR-155 has been implicated in placental development and can directly interact with a variety of targets, including angiotensin type II receptor 1 (AT1R) (Agtr1) mRNA.
Anya L. Arthurs   +8 more
doaj   +2 more sources

Angiotensin II Type 1 Receptor Antibodies and Increased Angiotensin II Sensitivity in Pregnant Rats [PDF]

open access: yesHypertension, 2011
Pregnant women who subsequently develop preeclampsia are highly sensitive to infused angiotensin (Ang) II; the sensitivity persists postpartum. Activating autoantibodies against the Ang II type 1 (AT 1 ) receptor are present in preeclampsia.
Katrin, Wenzel   +20 more
openaire   +3 more sources

Validation of six commercially available angiotensin II type 1 receptor antibodies [PDF]

open access: yesActa Biochimica et Biophysica Sinica
Li Bingjie   +5 more
doaj   +2 more sources

Upregulation of NADH/NADPH oxidase 4 by angiotensin II induces podocyte apoptosis [PDF]

open access: yesKidney Research and Clinical Practice, 2023
Background Angiotensin II induces glomerular and podocyte injury via systemic and local vasoconstrictive or non-hemodynamic effects including oxidative stress. The release of reactive oxygen species (ROS) from podocytes may participate in the development
Tae-Sun Ha   +3 more
doaj   +1 more source

Differential Regulation of Intracisternally Injected Angiotensin II-Induced Mechanical Allodynia and Thermal Hyperalgesia in Rats

open access: yesBiomedicines, 2023
The present study examined the underlying mechanisms of mechanical allodynia and thermal hyperalgesia induced by the intracisternal injection of angiotensin (Ang) II.
Ki-Don Park   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy